These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2470107)

  • 1. Natural killer cells.
    Herberman RB
    Prog Clin Biol Res; 1989; 288():161-7. PubMed ID: 2470107
    [No Abstract]   [Full Text] [Related]  

  • 2. "Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes.
    Sondel PM; Hank JA; Kohler PC; Chen BP; Sosman J
    Prog Clin Biol Res; 1989; 288():151-60. PubMed ID: 2654949
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural killer cells and tumor immunity: 1987.
    Hiserodt JC; Herberman RB
    Year Immunol; 1989; 4():201-7. PubMed ID: 2648702
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cells and naturally occurring antibodies as representatives of natural tumor immunity.
    Ehrlich R; Witz IP
    Pathobiol Annu; 1982; 12():85-113. PubMed ID: 6186979
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
    Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV
    Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cells and tumor immunity: 1985.
    Herberman RB
    Year Immunol; 1986; 2():254-60. PubMed ID: 3033946
    [No Abstract]   [Full Text] [Related]  

  • 8. Human and mouse "LAK" cells expanded in long-term cultures: in vitro and in vivo studies.
    Kedar E; Zeira E; Lebendiker Z; Weiss DW; Katan R; Shouval D
    Prog Clin Biol Res; 1987; 244():59-75. PubMed ID: 3498959
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans.
    Topalian SL; Rosenberg SA
    Important Adv Oncol; 1990; ():19-41. PubMed ID: 2182519
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K
    J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM; Blazar BR; Bach FH; Ochoa AC
    J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of tumoricidal effectors from the tumor-bearer's splenocytes and the prospects of their utilization for adoptive immunotherapy].
    Takagi H; Okuno K; Nakamura T; Kokudo S; Iwasa Z; Yasutomi M
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):721-7. PubMed ID: 3489799
    [No Abstract]   [Full Text] [Related]  

  • 13. The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.
    Ettinghausen SE; Rosenberg SA
    Springer Semin Immunopathol; 1986; 9(1):51-71. PubMed ID: 3523804
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS; Hargrove ME; Ting CC
    Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon: a perspective.
    Weissman RM; Droller MJ
    Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of natural killer cell activity in random-bred Rowett athymic rats.
    Lotzová E; Savary CA; Stringfellow DA; Drewinko B; Gray KN; Raulston GL; Jardine JH
    Exp Cell Biol; 1984; 52(1-2):53-9. PubMed ID: 6698279
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimetastatic activity of lymphokine-activated killer cells to rat fibrosarcoma (WBT-2M) and rat mammary carcinoma (SST-2).
    Ba DN; Wang ZH; Li XB; Li DJ
    Chin Med J (Engl); 1987 Jan; 100(1):2-7. PubMed ID: 3109819
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2.
    Rosenberg SA; Mulé JJ
    Surgery; 1985 Sep; 98(3):437-44. PubMed ID: 3898451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible application of natural killer cells and interleukin-2 in therapy of human leukemia.
    Lotzová E
    Prog Clin Biol Res; 1987; 244():259-66. PubMed ID: 3498951
    [No Abstract]   [Full Text] [Related]  

  • 20. [Using LAK cells in the adoptive immunotherapy in cancers].
    Urushizaki I
    Rinsho Ketsueki; 1987 Oct; 28(10):1897-8. PubMed ID: 3502569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.